Inari Medical (NASDAQ:NARI – Free Report) had its price objective trimmed by Needham & Company LLC from $72.00 to $57.00 in a research note released on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts also recently commented on NARI. Truist Financial decreased their target price on shares […]
Inari Medical (NASDAQ:NARI – Free Report) had its price objective cut by Needham & Company LLC from $72.00 to $57.00 in a report issued on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. NARI has been the topic of a number of other reports. Piper Sandler downgraded shares of Inari […]
Inari Medical (NASDAQ:NARI – Free Report) had its price target lowered by Needham & Company LLC from $72.00 to $57.00 in a report issued on Wednesday, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. NARI has been the subject of several other research reports. Piper Sandler lowered Inari Medical […]
Inari Medical (NASDAQ:NARI – Get Free Report) will release its earnings data after the market closes on Tuesday, April 30th. Analysts expect Inari Medical to post earnings of ($0.16) per share for the quarter. Inari Medical has set its FY 2024 guidance at EPS.Investors that are interested in participating in the company’s conference call can […]